The Latest Cardiac and Vascular News
PLANO, Texas, Sept. 16, 2024 /PRNewswire/ — Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the CLEANER Vac™ Thrombectomy System for the…
PALM SPRINGS, Calif., Sept. 6, 2024 /PRNewswire/ — Leading physicians and researchers will present results from 21 clinical trials from Sunday, November 3, to Tuesday, November 5, at the annual VIVA and The VEINS conferences at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) is a…
September 05, 2024 09:09 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) clinical registry today announced the Carotid Care Quality Champion recognition program. The program honors healthcare organizations across the country dedicated to improving the safety and effectiveness of vascular care through participation in the VQI’s […]
September 03, 2024 08:30 AM Eastern Daylight Time LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced European CE Mark approval of the […]
August 29, 2024 08:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions, announced today that the U.S. Food and Drug Administration (FDA) has […]
IRVINE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that data from the PEERLESS trial will be presented by Dr. Wissam Jaber, Professor of Medicine at Emory University School of Medicine, during the Late-Breaking Clinical Trial Sessions at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium in Washington, D.C. The presentation will take place on October 29th.
– Results presented at the Department of Defense’s Military Health System Research Symposium (MHSRS) –
CHAPEL HILL, N.C., Aug. 27, 2024 /PRNewswire/ — SonoVascular, Inc., a private medical device company, has announced the successful initiation of its first human study with its SonoThrombectomyä System. The SonoVascular platform is an innovative ultrasound facilitated, thrombolytic…
PHILADELPHIA, Aug. 22, 2024 /PRNewswire/ — The National Blood Clot Alliance www.stoptheclot.org, the nation’s leading patient advocacy organization dedicated to advancing the prevention, early diagnosis, and successful treatment of venous blood clots, has announced the appointment of…
The agreement follows the successful completion of Phase 1 which evaluated the viability of LIBERTY as a remote telesurgery platform
